Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Anne, Rahbech"'
Autor:
Helena Borland Madsen, Jon Ambæk Durhuus, Ove Andersen, Per thor Straten, Anne Rahbech, Claus Desler
Publikováno v:
npj Metabolic Health and Disease, Vol 2, Iss 1, Pp 1-8 (2024)
Abstract The COVID-19 pandemic, caused by SARS-CoV-2, has resulted in widespread morbidity and mortality, with a significant portion of the affected population experiencing long-term health complications. This review explores the mechanisms of mitoch
Externí odkaz:
https://doaj.org/article/4083a3d8cd894abaa18d46f573504756
Autor:
Per thor Straten, Cécile Gouttefangeas, Juliane Schuhmacher, Sara Fresnillo Saló, Anne Rahbech, Sara Pedersen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/ed6149746fdb49a6a9f92d00d3e6b54a
Autor:
Ana Micaela Carnaz Simões, Morten Orebo Holmström, Pia Aehnlich, Anne Rahbech, Marlies J. W. Peeters, Aneta Radziwon-Balicka, Carlos Zamora, Tobias Wirenfeldt Klausen, Vibe Skov, Lasse Kjær, Christina Ellervik, Daniel El Fassi, Silvia Vidal, Hans Carl Hasselbalch, Mads Hald Andersen, Per thor Straten
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/593b961b919e482caa28a6ae47f86f5f
Autor:
Ana Micaela Carnaz Simões, Morten Orebo Holmström, Pia Aehnlich, Anne Rahbech, Marlies J. W. Peeters, Aneta Radziwon-Balicka, Carlos Zamora, Tobias Wirenfeldt Klausen, Vibe Skov, Lasse Kjær, Christina Ellervik, Daniel El Fassi, Silvia Vidal, Hans Carl Hasselbalch, Mads Hald Andersen, Per thor Straten
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Myeloproliferative neoplasms (MPN) are chronic cancers of the hematopoietic stem cells in the bone marrow, and patients often harbor elevated numbers of circulating platelets (PLT). We investigated the frequencies of circulating PLT-lymphocyte aggreg
Externí odkaz:
https://doaj.org/article/4d831d41a2bb43238209bbff284b2564
Autor:
Richard M. Powell, Marlies J. W. Peeters, Anne Rahbech, Pia Aehnlich, Tina Seremet, Per thor Straten
Publikováno v:
Vaccines, Vol 9, Iss 11, p 1294 (2021)
There is an increasing interest in the development of Receptor Tyrosine Kinases inhibitors (RTKIs) for cancer treatment, as dysregulation of RTK expression can govern oncogenesis. Among the newer generations of RTKIs, many target Mer Tyrosine Kinase
Externí odkaz:
https://doaj.org/article/ea4b29a1d4364e7390284cee2fd8917d
Autor:
Per thor Straten, Claus Desler, Marco Donia, Jürgen C. Becker, Özcan Met, Lene Juel Rasmussen, Inge Marie Svane, Gitte Holmen Olofsson, Mads Hald Andersen, Hólmfridur R. Halldórsdóttir, Evelina Martinenaite, Ana Micaela Carnaz Simões, Tina Seremet, Signe K. Skadborg, Anne Rahbech, Cathrin Ritter, Arianna Draghi, Donata Dulkeviciute, Marlies J.W. Peeters
Supplementary Methods. Table S1: primer sequences. Figure S1: PROS1 and MERTK co-expression on 3-day activated CD8+ T cells. Figure S2: TAM receptors TYRO3 and AXL are nearly absent or absent on CD8+ T cells. Figure S3: Phosphatidylserine is not a li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8718ffea8ac46e33c6d349343916074b
https://doi.org/10.1158/2326-6066.22543074.v1
https://doi.org/10.1158/2326-6066.22543074.v1
Autor:
Per thor Straten, Claus Desler, Marco Donia, Jürgen C. Becker, Özcan Met, Lene Juel Rasmussen, Inge Marie Svane, Gitte Holmen Olofsson, Mads Hald Andersen, Hólmfridur R. Halldórsdóttir, Evelina Martinenaite, Ana Micaela Carnaz Simões, Tina Seremet, Signe K. Skadborg, Anne Rahbech, Cathrin Ritter, Arianna Draghi, Donata Dulkeviciute, Marlies J.W. Peeters
The TAM family of receptor tyrosine kinases (TYRO3, AXL, and MERTK) is known to be expressed on antigen-presenting cells and function as oncogenic drivers and as inhibitors of inflammatory responses. Both human and mouse CD8+ T cells are thought to b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::551d6c05a67ca18e22dde038a7b856c4
https://doi.org/10.1158/2326-6066.c.6550128.v1
https://doi.org/10.1158/2326-6066.c.6550128.v1
Autor:
Per thor Straten, Claus Desler, Marco Donia, Jürgen C. Becker, Özcan Met, Lene Juel Rasmussen, Inge Marie Svane, Gitte Holmen Olofsson, Mads Hald Andersen, Hólmfridur R. Halldórsdóttir, Evelina Martinenaite, Ana Micaela Carnaz Simões, Tina Seremet, Signe K. Skadborg, Anne Rahbech, Cathrin Ritter, Arianna Draghi, Donata Dulkeviciute, Marlies J.W. Peeters
Raw data sets from gene expression analysis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::347b5dc539b07da76a39070863bcd2cb
https://doi.org/10.1158/2326-6066.22543071
https://doi.org/10.1158/2326-6066.22543071
Autor:
Per thor Straten, Özcan Met, Kasper Mølgaard, Marian Peeters, Inge Marie Svane, Anne Rahbech, Claus Desler
Publikováno v:
Journal of Visualized Experiments.
During activation, the metabolism of T cells adapts to changes that impact their fate. An increase in mitochondrial oxidative phosphorylation is indispensable for T cell activation, and the survival of memory T cells is dependent on mitochondrial rem
Publikováno v:
Aehnlich, P, Powell, R M, Peeters, M J W, Rahbech, A & Straten, P T 2021, ' Tam receptor inhibition–implications for cancer and the immune system ', Cancers, vol. 13, no. 6, 1195, pp. 1-16 . https://doi.org/10.3390/cancers13061195
Cancers
Cancers, Vol 13, Iss 1195, p 1195 (2021)
Cancers
Cancers, Vol 13, Iss 1195, p 1195 (2021)
Simple Summary TAM receptors are a family of receptor tyrosine kinases, comprising Tyro3, Axl and MerTK. Their primary role is in digestion of dying cells by macrophages without alarming the immune system. TAM receptors are also expressed by cancer c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76fc124861687a9baf950c2607d6658f
https://curis.ku.dk/ws/files/259560566/cancers_13_01195_v2.pdf
https://curis.ku.dk/ws/files/259560566/cancers_13_01195_v2.pdf